We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Suppression of DNA Repair by H. pylori Paves the Way for Development of Gastric Cancer

By LabMedica International staff writers
Posted on 28 Jun 2015
Image: The stomach bacterium Helicobacter pylori changes the activity of genes in gastric cells (Photo courtesy of Max Planck Institute for Infection Biology).
Image: The stomach bacterium Helicobacter pylori changes the activity of genes in gastric cells (Photo courtesy of Max Planck Institute for Infection Biology).
A team of molecular microbiologists has established what they believe to be the definitive link between Helicobacter pylori infection and the development of gastric cancer.

Infection with the human pathogen H. pylori is a major risk factor for gastric cancer. However, since the bacterium exerts multiple genotoxic effects, investigators at the Max Planck Institute for Infection Biology (Berlin, Germany) chose to examine how DNA damage accumulated in gastric cells following H. pylori infection.

The investigators utilized a new technique for cultivating cultures of normal human stomach tissue. This material replaced the use of cancer cell lines whose mutated genomes obscured early changes induced by H. pylori.

Results published in the June 11, 2015, online edition of the journal Cell Reports revealed that the activity of several sub-telomeric genes responsible for recognizing and repairing damaged DNA was suppressed during the course of the infection. Infection impaired several host cell DNA repair factors, the extent of which depended on a functional H. pylori cag pathogenicity island (cagPAI). This led to accumulation of a unique DNA damage pattern, preferentially in transcribed regions and proximal to telomeres, in both gastric cell lines and primary gastric epithelial cells. The observed pattern correlated with focal amplifications in adenocarcinomas of the stomach and partly overlapped with known cancer genes.

They authors described their interpretation of the impact of H. pylori infection on host cell DNA by saying, "We thus demonstrate an impact of a bacterial infection directed toward specific host genomic regions and describe underlying characteristics that make such regions more likely to acquire heritable changes during infection, which could contribute to cellular transformation."

Related Links:

Max Planck Institute for Infection Biology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)

Channels

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more